Background -Supernatants from epithelial cell cultures enhance eosinophil survival in vitro, this effect being abrogated by previous incubation of eosinophils with glucocorticosteroids. This
desonide. Methods -Human epithelial cell conditioned media (HECM) was generated from cultured epithelial cells obtained from healthy nasal mucosa and polyps. Eosinophils isolated from the peripheral blood were incubated with different corticosteroids for one hour before the addition of HECM. The inhibitory potency of the four steroids on the eosinophil survival index was compared using the concentration of steroid causing 50% inhibition (IC50). Results -Eosinophil survival was increased by HECM from both healthy nasal mucosa and polyps. All four steroids blocked HECM-induced eosinophil survival in a dose-dependent manner. On healthy nasal mucosa methylprednisolone was the least potent (IC50 = 536 nM), deflazacort (IC50 = 264 nM) was twice as potent as methylprednisolone, while budesonide and dexamethasone were approximately nine times as potent (both IC50 = 58 nM). When potency was evaluated on the promoting effects of the HECM obtained from nasal polyps, the inhibitory potencies were lower and consequently the IC50 values were higher when compared with HECM generated from healthy nasal mucosa: methylprednisolone (IC50 = 546 nM), deflazacort (IC5s = 390 nM), dexa Preparation of collagen coated culture plates Collagen coated culture dishes were prepared as previously described. 6 The bottom of the wells from 24-well culture plates (Costar, Cambridge, USA) was covered with bovine dermal purified collagen (Vitrogen 100) and allowed to dry overnight. The collagen was then exposed to 0 5 ml of 3.5% NH40H in distilled water for 25 minutes, washed with distilled water, exposed to 0 5 ml of 2 5% glutaraldehyde in phosphate buffered saline (PBS) for 10 minutes, and washed twice again with distilled water. Ham's F-12 medium (2 ml) supplemented with antibiotics was then added to each well and the plates were placed in a 5% carbon dioxide incubator chamber at 37°C until used.
Cell cultures Nasal epithelial cells from normal mucosa or polyps were isolated by protease digestion as previously reported.6 Tissue specimens were rinsed 2-3 times with Ham's F-12 medium supplemented with antibiotics and incubated in 0-1% protease type XIV in Ham's F-12 medium for 16 hours at 4°C. After incubation 10% fetal bovine serum was added to neutralise protease activity and epithelial cells were detached by gentle agitation. Cell suspensions were filtered through a 60 mesh cell dissociation sieve (Sigma) and centrifuged at 500 g for 10 minutes at room temperature. The cell pellet was then resuspended in hormonally defined Ham's F-12 culture medium (Ham's HD) with the following reagents: 100 IU/ml penicillin, 100 nM hydrocortisone. Cell suspensions (105 cells/well) were plated on collagen coated wells in 2 ml Ham's HD medium and cultured in a 5% carbon dioxide humidified atmosphere at 37°C. The culture medium was changed at day 1 and every two days thereafter. Monolayer cell confluence was achieved after 6-10 days of culture.
GENERATION OF HUMAN EPITHELIAL
CONDITIONED MEDIA (HECM) When epithelial cell cultures reached confluence Ham's HD medium was switched to RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 IU/ml penicillin, 100 jig/ml streptomycin, 2 jig/ml amphotericin B, 150 jug/ml glutamine, and 25 nM Hepes buffer (RPMI 10%). Human epithelial cell conditioned medium (HECM) was generated after 48 hours of incubation with RPMI 10%, harvested from cultures, centrifuged at 400g for 10 minutes at room temperature, sterilised through 0-22 jm filters (Millipore), and stored at -70°C until used.
EOSINOPHIL ISOLATION
Peripheral blood eosinophils were obtained from atopic and non-atopic subjects with more than 3% eosinophils in peripheral blood using a method previously described.6 Percoll solution with a density of 1130g/ml was diluted with 10 x PBS to obtain an osmolarity of 310-320mOsm/kg and diluted with 1N PBS to obtain concentrations of 65% and 75%. Fifteen ml of the 65% Percoll solution was placed in 50 ml conical tubes and 15 ml of the 75% Percoll solution was layered below by means ofa narrow catheter placed at the bottom of the tube. Whole blood (100 ml) anticoagulated with 0 3% EDTA was incubated with 1 jM N-formyl-methionyl-leucyl-phenylalanine in a shaking water bath at 37°C for 20 minutes; 15 ml blood was then layered above the Percoll gradients and centrifuged at 400 g for 25 minutes at room temperature. Plasma and mononuclear/neutrophil bands located above the Percoll gradients were aspirated and discarded; 10 ml ofthe eosinophil band, located between the 65% and 75% Percoll layers, were collected and mixed with RPMI 10% and centrifuged at 400 g for 10 minutes at room temperature. Contaminant erythrocytes were removed by cold hypotonic lysis. The cell suspension was washed and resuspended in RPMI 10%. Cell viability (>95%) was assessed by Trypan blue dye exclusion and the percentage of eosinophils obtained (>90%) was quantified by cytocentrifuge smears stained with MayGruinwald-Giemsa.
EOSINOPHIL CULTURES
The effect on eosinophil survival of HECM, generated from both healthy nasal mucosa and nasal polyps, was measured. Eosinophils at a concentration of approximately 250 000/ml were incubated in six well tissue cultures (Sterling Ltd, Feltham, UK) with or without (negative control) HECM and the survival index was assessed at day 4. The HECM concentrations used were 10% for nasal polyps and 25% for healthy nasal mucosa. These concentrations were selected because they were found previously to be equipotent with regard to eosinophil survival priming effect. 6 The effect ofsteroids on HECM-induced eosinophil survival was tested by incubating systemic and inhaled steroids (from 100 pM to 10 giM) with eosinophil suspensions at 37°C over one hour before the addition of HECM. Dexamethasone and methylprednisolone were diluted in RPMI while deflazacort and budesonide were diluted in dimethyl sulphoxide. The final concentration of dimethyl sulphoxide (0-01%) used in the steroid experiments had no effect on eosinophil survival.
EOSINOPHIL SURVIVAL INDEX
The eosinophil survival index was calculated as follows: (number of eosinophils recovered)
x (percentage of eosinophil viability)/(number of eosinophils delivered on day 0).
DATA ANALYSIS
The statistical evaluation was performed on a microcomputer MacIntosh SE/30 (Apple Computer, Cupertino, California, USA) using the statistical software package Statview 512 + (Brainpower Inc, Calabasas, California, USA). All results are expressed as mean (SE). The Student's t test for unpaired sample analysis was used for statistical comparisons, p<005 being considered statistically significant.
Results

EFFECTS OF GLUCOCORTICOSTEROIDS ON EOSINOPHIL SURVIVAL
Human epithelial cell conditioned media (HECM) at a concentration of 25% from healthy nasal mucosa (figure) and 10% from nasal polyps (table 1) significantly increased the eosinophil survival with respect to controls (p<00001). No differences were found in the effect on eosinophil survival between HECM Effect of (A) methylprednisolone, (B) dexamethasone, (C) deflazacort, and (D) budesonide on eosinophil survival induced by human epithelial cell conditioned media (HECM) from healthy nasal mucosa. C= eosinophil survival at day 4 when incubated with culture media alone (negative control), HECM = eosinophil survival at day 4 after stimulation with epithelial cell secretions (positive control). Preincubation of eosinophils with methylprednisolone (from 10'8 to 10-5M, n=8), dexamethasone (from 10-9 to 10-5M, n=5), deflazacort (from 10 generated from healthy nasal mucosa (25% concentration) and HECM generated from nasal polyps (10% concentration). These findings confirm a previous study which showed that both concentrations show a similar capacity to increase eosinophil survival.6 Furthermore, the preincubation ofeosinophils with the four steroids decreased the survival index in a dose-dependent manner in experiments using HECM from both healthy nasal mucosa (figure) and nasal polyps (table 1).
In the experiments using HECM from healthy nasal mucosa the lowest effective steroid concentration was 10-9M for budesonide and deflazacort, 10 5M for dexamethasone, and 10 -7M for methylprednisolone (figure). When using HECM from nasal polyps the lowest effective steroid concentration was 10 7M for budesonide, dexamethasone, and methylprednisolone, and 10-6M for deflazacort (table 1) .
COMPARISON OF INHIBITORY POTENCY OF STEROIDS ON EOSINOPHIL SURVIVAL
The inhibitory potency of the four steroids on the eosinophil survival index was compared by using the IC50 value (table 2). The IC50 represents the concentration of the drug at which 50% of inhibition is produced. Budesonide and dexamethasone showed a similar potency and proved to be the most active, followed by deflazacort and methylprednisolone. With the exception of methylprednisolone, the effects of these steroids were lower on eosinophil survival promoted by HECM from nasal polyps than from healthy nasal mucosa.
A scale of the relative inhibitory potency of these steroids was made by giving a value of 1 to the inhibitory effect ofthe least potent steroid (methylprednisolone) (table 2). Deflazacort was approximately twice as potent as methylprednisolone while budesonide and dexamethasone were nine (nasal mucosa) and seven (nasal polyps) times as potent. Our results confirm previous studies showing the impaired ability of supernatants to prolong eosinophil survival when steroids are added to a culture of eosinophils primed with epithelial cell supematants.56 Our method proved to be able to detect differences among steroids.
According to previous studies the antiinflammatory activity of dexamethasone is five times more potent than that of methylprednisolone.7 In our study we found the inhibitory effect of dexamethasone on eosinophil survival to be 7-9 times stronger than the effect exerted by methylprednisolone.
The potency of steroids has been compared by evaluating their effect on IgE mediated histamine release from basophils.8 With this in vitro model budesonide proved to be more potent than dexamethasone. These results contrast with our study which showed that both steroids exert similar inhibitory effects on eosinophil survival promoted by epithelial cell supematants.
Investigation of new glucocorticosteroid molecules is usually carried out using animal models such as the cotton pellet model and acute ear inflammation.9'0 The skin vasoconstrictor model of Place has also been extensively used to assess the anti-inflammatory potency of steroids." Although these and other models are useful in comparing the potency of different steroids, the inflammatory process involved in these experimental studies differs with respect to the airway inflammatory reaction present in bronchial asthma. The lack of eosinophilic infiltration in these animal models is the most striking difference. These differences might explain, at least in part, discrepancies between experimental studies with animals and clinical trials. For instance, using the ear oedema model in mice the potency of inhibition of inflammation for budesonide with respect to beclomethasone was 1 to 0 4. 
